Robot model
hinotori
Japan first domestically manufactured robotic-assisted surgery system, developed by Medicaroid (Kawasaki-Sysmex joint venture).
- Manufacturer
- Medicaroid
- Form factor
- surgical
- Maturity
- commercial
- Lifecycle
- active
Overview
Japan first domestically manufactured robotic-assisted surgery system, developed by Medicaroid (Kawasaki-Sysmex joint venture). Approved in Japan (2020), Singapore (2023), Malaysia (2024), Vietnam (2026), and CE-marked under MDR (July 2026). Authorized for urology, general surgery, gynecology, and thoracic surgery. Approximately 20,000 procedures performed globally.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Verified deployments
- None on file
- Sources on file
- 1 source, view all
No verified deployments on file. DEPLOY tracks independently-sourced deployment evidence separately from manufacturer capability claims.
Key facts
Japan approval
CE mark
Asia approvals
Specialties
Procedures
Data & sources
News coverage
1
1 source backing this record.View all →
Pricing
No verified price is on record for hinotori. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
hinotori on the deployment map
Where hinotori is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 18, 2026
Added to the verified registry
Regulatory filings (1)
- ce_markce mark · eucleared
Safety record
No incidents on record for hinotori.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (1)
Common questions
- What is hinotori?
- Japan first domestically manufactured robotic-assisted surgery system, developed by Medicaroid (Kawasaki-Sysmex joint venture). Approved in Japan (2020), Singapore (2023), Malaysia (2024), Vietnam (2026), and CE-marked under MDR (July 2026). Authorized for urology, general surgery, gynecology, and thoracic surgery. Approximately 20,000 procedures performed globally.
- How much does hinotori cost?
- hinotori's price is not publicly disclosed. DEPLOY has no verified price on record for hinotori from Medicaroid. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
- Is hinotori actually deployed in the real world?
- hinotori is recorded at the commercial stage, but DEPLOY has no deployment verified at a named site yet; vendor deployment claims are not independently confirmed here. Manufacturer capability claims should be read as claims pending independent verification.
- Who makes hinotori?
- hinotori is made by Medicaroid, based in Kobe, Hyogo Prefecture, Japan, founded in 2013.
- Can you buy hinotori?
- hinotori is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
- Is hinotori approved by regulators?
- hinotori has 1 regulatory record on the DEPLOY registry: CE marking, cleared. See the Regulatory filings section for each agency source.
- What are alternatives to hinotori?
- On the DEPLOY registry, comparable surgical robots to hinotori include Toumai, da Vinci (and Ion), Epione, Hugo RAS.
- How does hinotori compare to Toumai?
- hinotori and Toumai (MicroPort MedBot · 8 deployments) are both surgical robots on the DEPLOY registry. hinotori has 0 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
- What is hinotori's maturity stage?
- hinotori is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
- Where is hinotori deployed?
- No verified deployments of hinotori are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
- Is hinotori safe?
- hinotori has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Unreviewed · 1 source (no primary) · last reviewed 2026-07-18
Verification posture
Unreviewed
Low confidence
Review state
Stable
Last reviewed 2026-07-18
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- secondary-trade-publication
- Trade publication
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for hinotori.Machine-readable surfaces
- Markdown mirror: /models/medicaroid-hinotori.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/f335a065-11e5-4058-923d-781c5420a4cd
- Revision history: /models/medicaroid-hinotori/history
- Data documentation: /data
- Query this programmatically: Deploy MCP